30 years of tissue engineering, what has been achieved?

test tube

(Bill Oxford, Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Daniel Heath, Lecturer, Biomedical Engineering, University of Melbourne


The idea of tissue engineering emerged just over 30 years ago, in 1988. The two men credited with doing the seminal work in this field are Joseph Vacanti, a surgeon, and Robert Langer, a professor at the Massachusetts Institute of Technology. However, the term “tissue engineering” was not a mainstream buzzword until almost a decade later when the infamous “Vacanti mouse” – the mouse with a human ear on its back – was revealed.

The mouse evoked backlash from animal rights activists, and fear of genetic engineering from many who did not understand the science. For many others, the reaction was one of excitement and wonder. “If we can grow a human ear, why not a kidney, a liver, an eye?” And thus emerged an era of tissue engineering filled with hope – and hype.

The Vacanti mouse is still impressive to this day, and represented a major step forward in science. However, many still don’t understand what exactly the researchers did. The ear was actually a mesh of biodegradable plastic that was moulded into the desired shape, sprinkled with cartilage cells collected from a cow, and implanted under the skin of the mouse. The researchers removed the ‘ears’ after 12 weeks, and found that some new cartilage had been generated within the structure.

The basic premise of tissue engineering remains the same today. In general, a biodegradable material is formed into the shape of a target organ or tissues, this structure is often referred to as a “scaffold”. The scaffold is then seeded with the appropriate cell types. After implantation or maturation in a lab, it is hoped that the scaffold will slowly degrade away and, as it does, the cells will organise themselves and reconstruct a functional organ or tissue.

Tissue engineering in orthopaedic sports medicine
Image: Journal of ISAKOS

However, despite 30 years of dedicated research, we are still relying on organ donation rather than growing kidneys, livers, and hearts in the lab. So the question is – what real-world applications has this research produced?

We interviewed Professor Andrea O’Connor, a tissue engineering expert and the Head of the Department of Biomedical Engineering at the University of Melbourne, to find out.

Daniel Heath – Has tissue engineering made any real clinical impact?

Andrea O’Connor – Oh, definitely. Two of the most successful examples are INTEGRA and Osteopore. INTEGRA is used to help repair skin. The material is placed over a damaged section of skin, usually after a burn. The material has two layers. The inner layer, the one that is in contact with the damaged tissue, is a matrix of collagen. The collagen helps new skin cells and blood vessels grow into the injury to aid in repair. The outer layer is a non-degradable film that acts as a barrier to help prevent infection and loss of fluids from the injury site. A couple of weeks after treatment, the outer layer is peeled off, revealing a newly regenerated dermis [the inner layer of skin]. Osteopore is another success story. This is a porous biodegradable material that is used to repair bone during craniofacial surgery.

DH – What are the main roadblocks that are preventing tissue engineering from making a bigger impact and how can these challenges be addressed?

AO – In my opinion, one of the biggest challenges is vascularisation. In the body, cells in almost all of our tissues are within about 200 micrometers of a blood vessel. These blood vessels are critical to the survival of the cells. Without them, the cells don’t receive enough oxygen or nutrients and they die. 200 micrometers is a very short distance, we’re talking about the width of a few human hairs. Researchers have actually become pretty good at engineering tissues in the lab that contain a blood vessel network. However, when we implant these structures, the vessels are not able to connect to the patient’s blood vessels fast enough. This means that the tissue we worked so hard to construct in the lab may not survive the implantation process.

I think 3D printing and similar technologies will really help answer these questions. A lot of researchers around the world are looking at fabricating structures that contain preformed vascular channels that can be rapidly connected to a blood supply. I’m hopeful that this will let us build larger and more successful tissue engineered structures.

She said other challenges exist, such as sourcing the appropriate type and number of cells needed to populate the scaffold.

AO: If you’re trying to grow a kidney, for instance, you need a large number of the cell types that are found in the kidney. However, where do you get them from? Most people are quite attached to their kidneys! Additionally, there are many different types of cell present in a kidney, and they are organised in very complicated structures, and without this structure, a tissue engineered kidney wouldn’t function correctly.

Currently, a lot of people are looking at isolating stem cells from a patient, growing these to large cell numbers, differentiating them into the appropriate cell types, and then using these cells to populate the tissue engineering scaffold. I’m also hopeful that 3D printing will play a role in helping organise these cells into the right structures so that we can build more functional tissues.

Other big hurdles that slow the implementation of tissue engineering in the clinic are regulatory and commercial. New technologies have to go through many years of clinical trials. We have to make sure that these treatments are safe and beneficial before we can use them regularly as a treatment. However, this rigorous testing does slow the speed at which new treatments can be used to help the general population.

Also, these clinical trials costs millions of dollars. To make that happen, you have to be able to convince a large company or venture capitalists to invest in the development of the technology. Many very promising advances aren’t able to find sufficient funding to carry the invention all the way to the clinic. We call the stage between development in the lab and clinical trials “the valley of death”, and many technologies don’t make their way through that valley.

DH – What is the current state of the art in the field and where will tissue engineering go in the next five years?

AO – In addition to efforts to continue engineering whole organs or tissues for therapeutic application, exciting areas of development are organoids and microphysiological systems. While it’s challenging to generate a whole kidney and other organs, we can grow smaller versions of them in the lab that replicate some of their key functions.

Many research groups are connecting these organoids together using microfluidics to create something approaching aspects of a “human body on a chip”. These systems have a lot of potential in the areas of drug screening and personalised medicine.

Currently, drugs are still tested in animals. However, this is ethically difficult and it’s very well known that most animals do not respond the same way to many drugs as humans. We have the potential here to create platforms that allow drugs to be screened in a very human-like system before they’re actually tested in a person. This will likely help us reduce the number of animal experiments that are required and provide us with much better information on how a drug interacts with human physiology.

Thirty years is a short time in the development of a completely new field of science, especially one that operates in the complex and highly regulated medical space. To date, tissue engineering advances have been very successfully translated from the lab bench to the clinic, and thousands of individuals have benefitted.

With continued research, the field will continue to mature, and new and exciting treatments will make their way into clinical practice. However, this will require continued funding in this area of science, concerted efforts from gifted scientists and engineers to address the outstanding challenges in the field, and championing of these technologies by industry to make sure that they successfully navigate through the valley of technological death.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Digital distrust: We’re losing faith in technology to solve the world’s problems

This Canadian company transforms plastic waste into building materials

UN agency ramps up effort to counter growing nuclear threat from cyberspace

Germany objects to EU Commission’s plan for a Eurozone bank deposits insurance scheme but Berlin could go along

This is what’s happening to the Amazon, according to NASA

These 3 innovative solar farms show why this renewable technology is hot right now

From fire to fake snow – the global consequences of the climate crisis

Blockchain is not a magic bullet for security. Can it be trusted?

Civil society organisations disenchanted with “Youth Guarantee”

Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing

Where is heading Putin’s Russia?

Skills, not job titles, are the new metric for the labour market

How we planted more than 5,000 trees during the COVID-19 pandemic

This is how Middle Eastern retailers can keep up with e-commerce

UN chief calls for ‘increased commitment’ to resolution on 10th anniversary of Georgia conflict

In the future, no one should be excluded from healthcare

Eurozone’s credibility rock solid

These are the UK’s biggest trading partners

Draghi drafts a plan to donate more money to bankers, the era of ‘money for nothin’ is flourishing

The “Legend of the Sun” wishes you Happy Chinese New Year 2015 from Brussels

European Agenda on Migration four years on: Marked progress needs consolidating in face of volatile situation

Mental health and suicide prevention-what can be done to increase access to mental health services in my region?

World Economic Forum CEO Climate Leaders call for continued action toward net-zero emissions

What next for Europe? Three (completely) different Davos views

Record numbers of people in the UK have applied to study nursing

5 Black heroes of the environmental movement

New UN-Syrian Action Plan signals an ‘important day’ for child protection, says UN envoy

Why today’s leaders need to know about the power of narratives

The gender gap of medicine in 2018

How COVID-19 is making companies act for the long term

Ecocraft: take gaming to another level by greening Minecraft

Is Eurozone heading for disinflation?

Fisherwomen of Lake Chad show optimism in face of multiple challenges

Myanmar military committed ‘routine, systematic’ sexual violence against ethnic minorities, UN experts find

Britain and Germany change attitude towards the European Union

Global warming: our responsibility

Growth is running out of steam. How do we prepare for the next crisis?

Mali’s ‘self-defence’ groups must face justice, after deadly intercommunal attacks

How innovation from within is transforming International Organizations as well as lives

Joint EU-U.S. statement following the EU-U.S. Justice and Home Affairs Ministerial Meeting

Youth Guarantee putting young people in jobs

COP24 negotiations: Why reaching agreement on climate action is so complex

Commission sets moderate greenhouse gas reduction targets for 2030

10 Downing street: Another desperate attempt to unite Britain on Brexit

We had the hottest June ever this year – this is what happened around the world

Thailand gave healthcare to its entire population and the results were dramatic

What is the biggest benefit technology will have on ageing and longevity?

Turkey’s foreign bribery enforcement framework needs to be urgently strengthened and corporate liability legislation reformed

Youth not prioritised in new Commission

Amazon indigenous groups want to create a nature sanctuary the size of Mexico

Consumer protection: Deal on EU-wide rules for those sold faulty products

From drought to floods in Somalia; displacement and hunger worsen, says UN

Does Draghi have another ace up his sleeve given his Quantitative Easing failure?

Give a chance to the brothers of Ailan: reception of refugees in Greece

State aid: Commission approves €2.5 billion Italian scheme to support self-employed and healthcare professionals in context of coronavirus outbreak

How can you or your organization support the Hour of Pride initiative?

Fossil fuel support is rising again in a threat to climate change efforts

The 2019 European elections: A pro-European – and young – electorate with clear expectations

Revamp collective bargaining to prevent rising labour market inequalities in rapidly changing world of work

The European Sting at the Retail Forum for Sustainability live from Barcelona

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: